[HTML] frontiersin.org

[HTML][HTML] Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching

S Oba, T Hosoya, R Kaneshige, D Kawata… - Frontiers in …, 2023 - frontiersin.org
Background Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19).
Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical …
被引用次数：2 相关文章
[PDF] scienceopen.com

[PDF][PDF] Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching

S Oba, T Hosoya, R Kaneshige, D Kawata… - 2023 - scienceopen.com
Background: Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19).
Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical …

Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching.

S Oba, T Hosoya, R Kaneshige, D Kawata… - Frontiers in …, 2023 - europepmc.org
Background Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19).
Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical …
[HTML] nih.gov

[HTML][HTML] Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching

S Oba, T Hosoya, R Kaneshige, D Kawata… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19).
Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical …

Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching

S Oba, T Hosoya, R Kaneshige… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19).
Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical …